Jane Street Group LLC Sells 37,349 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO)

Jane Street Group LLC reduced its position in shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) by 61.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 23,002 shares of the medical instruments supplier’s stock after selling 37,349 shares during the period. Jane Street Group LLC owned 0.05% of Harvard Bioscience worth $62,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. GSA Capital Partners LLP bought a new position in shares of Harvard Bioscience during the 3rd quarter worth about $30,000. SG Americas Securities LLC acquired a new stake in Harvard Bioscience during the 3rd quarter valued at $36,000. Avior Wealth Management LLC increased its stake in shares of Harvard Bioscience by 1,118.1% in the third quarter. Avior Wealth Management LLC now owns 14,569 shares of the medical instruments supplier’s stock valued at $39,000 after buying an additional 13,373 shares in the last quarter. Cubist Systematic Strategies LLC bought a new position in Harvard Bioscience in the 2nd quarter worth approximately $40,000. Finally, Landscape Capital Management L.L.C. acquired a new position in Harvard Bioscience during the 3rd quarter valued at about $50,000. 80.87% of the stock is currently owned by institutional investors.

Harvard Bioscience Trading Down 2.0 %

NASDAQ:HBIO opened at $1.98 on Thursday. The business’s 50-day moving average price is $2.19 and its two-hundred day moving average price is $2.58. Harvard Bioscience, Inc. has a 1-year low of $1.80 and a 1-year high of $4.93. The firm has a market capitalization of $86.36 million, a price-to-earnings ratio of -6.00 and a beta of 1.27. The company has a current ratio of 2.06, a quick ratio of 0.91 and a debt-to-equity ratio of 0.52.

Harvard Bioscience Profile

Harvard Bioscience, Inc develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings.